(Reuters) -Eyenovia said on Friday it would terminate a late-stage study for its experimental drug-device combination to treat an eye disease after failing the main goal of slowing the progression of ...
Eyenovia will discontinue a late-stage study for its experimental drug-device combination to treat near-sightedness in children after it failed to slow the condition's progression, sending its shares ...